S&P 500
(-0.89%) 5 026.45 points
Dow Jones
(-1.25%) 37 980 points
Nasdaq
(-1.30%) 15 508 points
Oil
(-0.24%) $82.61
Gas
(-0.42%) $1.646
Gold
(0.05%) $2 339.50
Silver
(-0.06%) $27.33
Platinum
(0.26%) $918.15
USD/EUR
(-0.21%) $0.933
USD/NOK
(0.00%) $10.98
USD/GBP
(-0.32%) $0.800
USD/RUB
(-0.06%) $92.26

Realtime updates for First Trust Heitman [PRME]

Exchange: NYSE Sector: Healthcare Industry: Biotechnology
BUY
100.00%
return 6.79%
SELL
50.00%
return 3.93%
Last Updated25 Apr 2024 @ 12:40

-9.04% $ 4.28

BUY 101991 min ago

@ $6.86

Issued: 14 Feb 2024 @ 15:49


Return: -37.68%


Previous signal: Feb 14 - 09:30


Previous signal: Sell


Return: 2.01 %

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 12:40):

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence...

Stats
Today's Volume 477 296
Average Volume 723 462
Market Cap 512.74M
EPS $0 ( 2024-03-14 )
Next earnings date ( $-0.470 ) 2024-05-09
Last Dividend $0.800 ( 2019-09-10 )
Next Dividend $0 ( N/A )
P/E -1.960
ATR14 $0.0120 (0.28%)
Insider Trading
Date Person Action Amount type
2024-02-29 Marrazzo Jeffrey D Buy 250 000 Stock Option (right to buy)
2024-02-20 Gv 2023 Gp, L.l.c. Buy 0 Common Stock
2024-02-25 Gottesdiener Keith Michael Buy 100 000 Stock Option (right to buy)
2024-02-21 Brudnick Richard Buy 135 747 Stock Option (right to buy)
2024-02-21 Duffield Jeremy Buy 180 995 Stock Option (right to buy)
INSIDER POWER
34.54
Last 97 transactions
Buy: 38 299 882 | Sell: 27 394 093

Volume Correlation

Long: -0.48 (neutral)
Short: 0.73 (moderate)
Signal:(52.49) Neutral

First Trust Heitman Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

First Trust Heitman Correlation - Currency/Commodity

The country flag -0.25
( neutral )
The country flag -0.08
( neutral )
The country flag 0.00
( neutral )
The country flag -0.39
( neutral )
The country flag 0.46
( neutral )
The country flag -0.08
( neutral )

First Trust Heitman Financials

Annual 2023
Revenue: $0
Gross Profit: $-4.65M (0.00 %)
EPS: $-2.18
Q4 2023
Revenue: $0
Gross Profit: $-1.25M (0.00 %)
EPS: $-0.670
Q3 2023
Revenue: $0
Gross Profit: $-4.37M (0.00 %)
EPS: $-0.550
Q2 2023
Revenue: $0
Gross Profit: $-4.59M (0.00 %)
EPS: $-0.470

Financial Reports:

No articles found.

First Trust Heitman Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

First Trust Heitman Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A
Information
First Dividend $0.0900 2015-12-23
Last Dividend $0.800 2019-09-10
Next Dividend $0 N/A
Payout Date 2019-09-12
Next Payout Date N/A
# dividends 15 --
Total Paid Out $3.83 --
Avg. Dividend % Per Year 0.00% --
Score 1.65 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-05-21)
$0 Estimate 0.00 %
Dividend Stability
0.09 Very Bad
Dividend Score
1.65
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
VGI Dividend Royal 2024-02-09 Monthly 13 7.36% 8.50
PHK Dividend Royal 2023-11-10 Monthly 22 6.88% 8.50
JQC Dividend Royal 2023-11-14 Monthly 22 6.56% 8.50
PCF Dividend King 2023-12-18 Monthly 38 7.05% 8.50
PVL Dividend King 2023-11-15 Monthly 14 9.37% 8.50
NCV Dividend Royal 2024-02-09 Monthly 22 7.68% 8.50
SBR Dividend Royal 2023-11-14 Monthly 38 7.74% 8.50
MTR Dividend Diamond 2023-10-30 Monthly 39 10.10% 8.50
PDI Dividend Royal 2023-11-10 Monthly 13 7.86% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM01.50000[0 - 0.5]
returnOnAssetsTTM-1.0221.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM-0.9371.500-10.00-10.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM2.530.8002.331.864[1 - 3]
quickRatioTTM2.160.8002.021.617[0.8 - 2.5]
cashRatioTTM0.7371.5007.0210.00[0.2 - 2]
debtRatioTTM0.0703-1.5008.83-10.00[0 - 0.6]
interestCoverageTTM440.771.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM-1.6992.00-0.566-1.132[0 - 30]
freeCashFlowPerShareTTM-1.7882.00-0.894-1.788[0 - 20]
debtEquityRatioTTM0.102-1.5009.59-10.00[0 - 2.5]
grossProfitMarginTTM01.000-3.33-3.33[0.2 - 0.8]
operatingProfitMarginTTM01.000-2.00-2.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-12.131.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score0.156

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-2.311.000-0.3340[1 - 100]
returnOnEquityTTM-0.9372.50-7.41-10.00[0.1 - 1.5]
freeCashFlowPerShareTTM-1.7882.00-0.596-1.788[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-1.6992.00-0.566-1.132[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.06631.500-2.890[0.5 - 2]
operatingCashFlowSalesRatioTTM01.000-2.500[0.1 - 0.5]
Total Score-1.950

First Trust Heitman

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators